UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39513 Outset Medical, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 20-0514392 (State or other jurisdiction ...

Outset Medical, Inc. (NASDAQ:OM) Q1 2021 Earnings Conference Call May 5, 2021 5:00 PM ET Company Participants Lynn Lewis - IR Leslie Trigg - President and CEO Rebecca Chambers - CFO Conference Call Participants Jamie Perse - Goldman Sachs Drew Ranieri - Morgan Stanley Danielle Antalffy - SVB Leerink Rick Wise - Stifel Suraj Kalia - Oppenheimer & Company Shagun Singh - Wells Fargo Operator Ladies and gentlemen, thank you for standing by, and welcome to the Outset Medical First Quarter 2021 Earnings Conferenc ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39513 Outset Medical, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 20-0514392 (State or other jurisdictio ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. YES ☐ NO ☒ For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39 ...

| --- | --- | |--------------------------------------------------------------|-------| | | | | | | | | | | | | | Outset Medical Fourth Quarter & Full Year 2020 Earnings Call | | | March 9, 2021 | | Forward-Looking Statements and Non-GAAP Information 2 This presentation and the accompanying oral statements contain forward-looking statements within the meaning of the federal securities laws. All statements other than statements of historical fact are forward-looking statements. In some cases, you can identify ...

Outset Medical, Inc. (NASDAQ:OM) Q4 2020 Earnings Conference Call March 9, 2021 5:00 PM ET Company Participants Lynn Lewis - Investor Relations Leslie Trigg - President & Chief Executive Officer Rebecca Chambers - Chief Financial Officer Conference Call Participants David Lewis - Morgan Stanley Amit Hazan - Goldman Sachs Danielle Antalffy - SVB Leerink Rick Wise - Stifel Suraj Kalia - Oppenheimer Operator Ladies and gentlemen, thank you for standing by and welcome to the Outset Medical Fourth Quarter and Fu ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39513 Outset Medical, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 20-0514392 (State or other jurisdi ...